FDA's Stephen Spielberg to Deliver Plenary at 2012 ISPE Annual Meeting

Print this page         

FOR IMMEDIATE RELEASE

Contact:
Danielle Hould
ISPE Communications Manager
Tel: +1-813-960-2105, ext. 277
Fax: +1 813.264.2816
dhould@ispe.org
www.ISPE.org

Top FDA Official Stephen P. Spielberg, MD, PhD, to
Deliver Plenary Address at 2012 ISPE Annual Meeting

(TAMPA, FLORIDA, USA, 12 September 2012)ISPE announced today that the FDA’s Deputy Commissioner for Medical Products and Tobacco, Stephen P. Spielberg, MD, PhD, will deliver a plenary address at the 2012 ISPE Annual Meeting, taking place 11-14 November in San Francisco, Calif. USA. Spielberg’s talk is titled “How the FDA is Advancing Regulatory Science through High Quality Collaboration,” and will discuss how the FDA is addressing challenges and taking advantage of opportunities to advance regulatory science through collaborations with organizations like ISPE.

The plenary session will also feature an address by Murray Aitken, Executive Director, IMS Institute for Healthcare Informatics. Aitken’s speech, titled “Top Priorities and Trends for the Pharmaceutical Industry,” will deliver a global analysis of the industry supported by quantifiable data, as well as a forecast of top priorities and trends through 2016, including content that will be exclusive to ISPE’s Annual Meeting.

The plenary session is part of a four-day conference program designed to give pharmaceutical professionals a better understanding of the industry’s current technical and regulatory challenges and an opportunity to engage in open dialog to solve those challenges. Two special sessions will be of particular interest for those concerned with pharmaceutical quality, regulatory considerations or next steps for the industry:

  • Executive Series: Distinguished industry leaders will participate in a strategic discussion of key areas identified by technical leaders as critical to the future of the pharmaceutical industry. Attendees will hear “Confessions of a Counterfeiter,” and other provocative discussion topics.
  • International Regulatory Summit: High-level regulators from North America, Europe, Asia and Latin America will discuss regional regulatory challenges and examine those challenges within the context of a global regulatory environment.

Watch this video to learn more about the 2012 ISPE Annual Meeting. Additional information, including complete education, speaker and registration details, is available at www.ISPE.org/2012AnnualMeeting.

About ISPE
ISPE, the International Society for Pharmaceutical Engineering, is a not-for-profit Society of 22,000 pharmaceutical professionals in 90 countries who use expert knowledge to create high-quality, cost-effective GMP solutions. ISPE will soon be recognized globally as the leading technical organization for professionals engaged in producing quality medicines and pharmaceutical devices across the entire product lifecycle. Founded in 1980, ISPE offers online learning opportunities for a global audience and has its worldwide headquarters in Tampa, Florida, USA, as well as offices in Brussels, Belgium, Singapore and Shanghai, China. Visit www.ISPE.org for additional Society news and information.

###

My ISPE

  • Click to go to My Communities of Practice
  • Click to go to My Affiliate or Chapter
  • Click to go to My Profile
Click to go to the Member Gift